FDA NDC Directory · JSON-LD · Markdown

EMEND

NDC 0006-3066 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic nameaprepitant
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryNew Drug Application (innovator) · App NDA207865
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsAPREPITANT (125 mg/1)
Marketing started20151217
Package count1

External sources

Source: openFDA. Public-domain (CC0).